Stockscreener 앱 받기
11.98
0.83%
-0.10
전일 마감가:
$12.08
열려 있는:
$12.12
하루 거래량:
1.64M
Relative Volume:
0.99
시가총액:
$1.34B
수익:
$577.74M
순이익/손실:
$-149.78M
주가수익비율:
-8.5571
EPS:
-1.4
순현금흐름:
$-78.21M
1주 성능:
-0.37%
1개월 성능:
+1.87%
6개월 성능:
-34.14%
1년 성능:
-28.26%
1일 변동 폭
$11.71
$12.15
1주일 범위
$11.71
$12.49
52주 변동 폭
$10.87
$34.13
Novocure Ltd Stock (NVCR) Company Profile
명칭
Novocure Ltd
전화
44 (0)15 3475 6700
주소
NO. 4 THE FORUM, ST. HELIER
NVCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVCR
Novocure Ltd
|
11.98 | 1.36B | 577.74M | -149.78M | -78.21M | -1.40 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Novocure Ltd Stock (NVCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-07-08 | 개시 | Ladenburg Thalmann | Buy |
| 2024-12-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-10-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-08-28 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-08-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | 개시 | SVB Securities | Outperform |
| 2023-07-31 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2023-06-07 | 업그레이드 | Wedbush | Underperform → Neutral |
| 2023-05-16 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-17 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-01-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-05 | 재확인 | H.C. Wainwright | Buy |
| 2022-11-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-10-24 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-07-05 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2022-05-16 | 개시 | H.C. Wainwright | Buy |
| 2022-02-08 | 개시 | Loop Capital | Buy |
| 2022-02-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-20 | 업그레이드 | Truist | Hold → Buy |
| 2022-01-03 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-07-01 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2021-01-25 | 재확인 | Piper Sandler | Overweight |
| 2020-09-23 | 개시 | Northland Capital | Outperform |
| 2020-09-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-09-17 | 다운그레이드 | Truist | Buy → Hold |
| 2020-06-01 | 재개 | Oppenheimer | Perform |
| 2020-05-01 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-03-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-07-29 | 업그레이드 | SunTrust | Hold → Buy |
| 2019-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-07-26 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2018-11-02 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-07-16 | 개시 | Evercore ISI | Outperform |
| 2018-04-18 | 재확인 | Mizuho | Buy |
| 2018-02-23 | 재확인 | Mizuho | Buy |
| 2017-05-24 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-07-29 | 재확인 | Wedbush | Outperform |
| 2016-01-19 | 개시 | Barclays | Underweight |
| 2015-12-02 | 개시 | Deutsche Bank | Hold |
모두보기
Novocure Ltd 주식(NVCR)의 최신 뉴스
Novocure at Wells Fargo Conference: Expanding Cancer Treatment Horizons - Investing.com
Is NovoCure Limited exposed to currency risks2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com
Strategies to average down on NovoCure LimitedJuly 2025 Outlook & Technical Pattern Based Buy Signals - Newser
Does NovoCure Limited show high probability of reboundEarnings Growth Summary & Consistent Return Strategy Ideas - Newser
Can NovoCure Limited recover in the next quarterTrend Reversal & Verified Technical Signals - Newser
What the charts say about NovoCure Limited today2025 AllTime Highs & Low Drawdown Investment Ideas - Newser
What to expect from NovoCure Limited in the next 30 daysTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Understanding NovoCure Limited’s price movementWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Is NovoCure Limited a top pick in the sectorJuly 2025 Summary & Daily Chart Pattern Signals - khodrobank.com
What machine learning models say about NovoCure LimitedMarket Growth Report & Breakout Confirmation Trade Signals - Newser
NovoCure (NVCR) Is Up 5.4% After Spain Reimburses TTFields Therapy—Has The Bull Case Changed? - Yahoo Finance
Can NovoCure Limited generate free cash flowJuly 2025 Reactions & Community Driven Trade Alerts - khodrobank.com
Is NovoCure Limited stock entering bullish territoryGap Up & Verified Entry Point Signals - Newser
How to forecast NovoCure Limited trends using time series2025 Market WrapUp & Stock Timing and Entry Methods - Newser
NovoCure Limited stock momentum explainedDip Buying & Reliable Entry Point Alerts - Newser
Identifying reversal signals in NovoCure LimitedTrade Volume Summary & Long-Term Growth Portfolio Plans - Newser
Price momentum metrics for NovoCure Limited explainedGap Down & Detailed Earnings Play Alerts - Newser
RSI Suggests Rebound May Be Near in NovoCure Limited getLinesFromResByArray error: size == 0 - 더경남뉴스
Nationwide Spanish Reimbursement for TTFields Could Be a Game Changer for NovoCure (NVCR) - simplywall.st
NovoCure Limited stock chart pattern explainedQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Using portfolio simulators with NovoCure Limited includedDollar Strength & Daily Profit Focused Screening - Newser
Using R and stats models for NovoCure Limited forecastingPortfolio Update Summary & AI Enhanced Trading Signals - Newser
Tools to assess NovoCure Limited’s risk profileAnalyst Upgrade & Momentum Based Trading Signals - Newser
NovoCure Limited Facing Inflection Point in Trend AnalysisWeekly Market Outlook & Risk Controlled Daily Plans - beatles.ru
Top chart patterns to watch in NovoCure Limited2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts - The Motley Fool
Analyzing recovery setups for NovoCure Limited investors2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Multi asset correlation models including NovoCure LimitedWeekly Volume Report & Community Shared Stock Ideas - Newser
Novocure Ltd (NVCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Novocure Ltd 주식 (NVCR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Stafford Kristin | Director |
Jun 03 '25 |
Sale |
17.28 |
999 |
17,259 |
3,054 |
| LEUNG GABRIEL | Director |
Jun 03 '25 |
Sale |
17.31 |
999 |
17,297 |
81,229 |
| Madden Martin J. | Director |
Jun 03 '25 |
Sale |
17.19 |
999 |
17,176 |
18,674 |
| Scannell Timothy J | Director |
Jun 03 '25 |
Sale |
17.32 |
999 |
17,299 |
6,018 |
| HILLEMAN JERYL L | Director |
Jun 03 '25 |
Sale |
17.26 |
999 |
17,247 |
5,591 |
| Ocean Allyson J | Director |
Jun 03 '25 |
Sale |
17.29 |
999 |
17,269 |
3,054 |
| VERNON W ANTHONY | Director |
Jun 03 '25 |
Sale |
17.35 |
999 |
17,329 |
167,887 |
| Hung David | Director |
Jun 03 '25 |
Sale |
17.30 |
999 |
17,280 |
12,195 |
| Leonard Frank X | EVP, Pres., Novocure Oncology |
Jun 02 '25 |
Sale |
17.50 |
30,196 |
528,413 |
168,452 |
0.38%
0.32%
자본화:
|
볼륨(24시간):